SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets earnings miss triggered a sharp selloff, with slower Search and ad growth and heavy AI infrastructure spending driving concerns about negative free cash flow and whether investment will pay off. Traders are split: some see the drop as an overreaction given strong Cloud growth, while others worry AI is weakening Search monetization and cash generation.

Alphabet Inc - Ordinary Shares - Class C

Alphabets earnings disappointment has fueled a sharp selloff, with traders focused on slower Search and ad growth, heavy AI infrastructure spending, and negative free cash flowand questioning whether AI investments will generate sufficient returns. Others view the drop as an overreaction, citing strong Google Cloud growth and treating the decline as a buying opportunity.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows post-earnings plunge is tied to an adjusted-profit miss and a softer outlook for near-term contracted revenue growth, renewing concerns about deceleration and whether AI will benefit or disrupt enterprise software. Traders are split between viewing the sharp selloff as an overreaction to otherwise solid growth and AI traction, and seeing it as a justified reset for a richly valued stock facing weaker forward momentum.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results beat expectations, with Azure growth accelerating to 48% and capital spending below forecasts, but shares gave back much of their initial post-earnings gain. Traders are debating whether strong cloud demand and cash generation outweigh concerns about continued AI spending and financing, alongside broader weakness following Alphabets results.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVA sold off sharply after an updated lifileucel lung-cancer study showed an overall response rate near prior results but much stronger responses in a small biomarker-selected subgroup. Traders are divided between viewing the subgroup findings as promising and worrying that the narrower population, need for prospective validation, and uncertain regulatory timeline weaken the near-term opportunity; some also cite high expectations and the companys communication as factors in the reaction.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons Q3 earnings report is the dominant focus, with traders watching AWS growth and margins, AI-related capital spending, and cash flow. Optimists point to strong cloud demand, while skeptics fear heavy spending and weak cash flow could prompt a selloff similar to Alphabets earnings reaction.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles long-term growth outlook and plan to reach positive free cash flow while limiting additional financing eased AI-spending and debt concerns, prompting a sharp rally. Traders remain divided over whether the projections are credible and executable, while some attribute the subsequent pullback to profit-taking and spillover from Alphabets results.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Lines quarterly earnings beat and raised full-year outlook are driving the rally, with traders welcoming signs of improved performance after a prolonged downturn. The community is broadly bullish and speculates that heavy short interest could amplify gains, while others point to debt, weaker yields, fuel costs and profit-taking as risks.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings Q3 update and the CEOs estimate that VK2735 may not reach commercialization for roughly two and a half years have fueled concern about the long wait, cash burn and potential dilution. Traders are divided over partnering or selling versus going it alone, while bulls cite Phase 3 progress and strong demand for obesity drugs as reasons for optimism.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report is driving attention, with record revenue and vehicle sales growth, strong adjusted EBITDA, and an upbeat full-year outlook supporting the sharp move higher. Traders are debating those growth signals against an EPS miss and narrowing adjusted EBITDA margins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.

Vaxxinity Inc - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0001
Prev Close	$0.027
Open	$0.0001
Dividend Yield	N/A
50-Day Moving Average	$0.0081
Beta	-3,533.32
Avg. Volume	5,608.67
PE Ratio	N/A

52-Week High	$0.20
52-Week Low	$0.00
Market Capitalization	$3.8M
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

VAXX Fundamentals